Skip to main navigation

Skip to footer

For Medicare For Providers For Brokers For Employers

Español

For Individuals & Families:

For Individuals & Families

Shop for Plans

Medical

Dental

Other Supplemental

Explore coverage through work

How to Buy Health Insurance

Types of Dental Insurance

Open Enrollment vs. Special Enrollment

See all topics

Shop for Medicare plans

Member Guide

Find a Doctor

Home

Knowledge Center

Wellness Library

Brolucizumab-dbll Injection

(broe" lue siz' ue mab)

WHY is this medicine prescribed?

Brolucizumab-dbll injection is used to treat wet age-related macular degeneration (AMD; an ongoing disease of the eye that causes loss of the ability to see straight ahead and may make it more difficult to read, drive, or perform other daily activities). Brolucizumab-dbll injection is also used to treat diabetic macular edema (DME; an eye disease caused by diabetes that can lead to vision loss). Brolucizumab-dbll is in a class of medications called vascular endothelial growth factor A (VEGF-A) antagonists. It works by stopping abnormal blood vessel growth and leakage in the eye(s) that may cause vision loss.

Are there OTHER USES for this medicine?

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

HOW should this medicine be used?

Brolucizumab-dbll comes as a solution (liquid) to be injected into the eye by a doctor. If you are receiving brolucizumab-dbll injection to treat wet AMD, it is usually given in a doctor's office once every 25 to 31 days for the first 3 doses, then once every 8 to 12 weeks. If you are receiving brolucizumab-dbll injection to treat DME, it is usually given in a doctor's office once every 39 to 45 days for the first 5 doses, then once every 8 to 12 weeks.

Before you receive a brolucizumab-dbll injection, your doctor will clean your eye to prevent infection and numb your eye to reduce discomfort during the injection. You may feel pressure in your eye when the medication is injected. After your injection, your doctor will need to examine your eyes before you leave the office.

Brolucizumab-dbll controls wet AMD and DME, but does not cure it. Your doctor will watch you carefully to see how well brolucizumab-dbll works for you. Talk to your doctor about how long you should continue treatment with brolucizumab-dbll.

Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.

What SPECIAL PRECAUTIONS should I follow?

Before receiving brolucizumab-dbll injection,

tell your doctor and pharmacist if you are allergic to brolucizumab-dbll, any other medications, or any of the ingredients in brolucizumab-dbll injection. Ask your pharmacist for a list of the ingredients.
tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take.
tell your doctor if you have an infection in or around the eye. Your doctor will probably tell you that you should not receive brolucizumab-dbll injection.
tell your doctor if you have any medical conditions.
tell your doctor if you are pregnant or plan to become pregnant. You should not become pregnant during your treatment with brolucizumab-dbll injection and for 1 month after your final dose. If you become pregnant while receiving brolucizumab-dbll injection, call your doctor.
tell your doctor if you breast-feeding. Do not breast-feed while you are receiving brolucizumab-dbll injection and for 1 month after your final dose.
you should know that brolucizumab-dbll injection may cause vision problems shortly after you receive the injection. Do not drive a car or operate machinery until your vision is back to normal.

What SPECIAL DIETARY instructions should I follow?

Unless your doctor tells you otherwise, continue your normal diet.

What should I do IF I FORGET to take a dose?

If you miss an appointment to receive brolucizumab-dbll injection, call your doctor as soon as possible.

What SIDE EFFECTS can this medicine cause?

Some side effects from brolucizumab-dbll injection can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:

eye pain, redness, or sensitivity to light
changes in vision
seeing ''floaters'' or small specks
bleeding in or around the eye
swelling of the eye or eyelid
rash, hives, itching, or redness

Brolucizumab-dbll may cause other side effects. Call your doctor if you have any unusual problems while receiving this medication.

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

What OTHER INFORMATION should I know?

Keep all appointments with your doctor.

Ask your pharmacist any questions you have about brolucizumab-dbll injection.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Brand Name(s): Beovu^®

This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.

The American Society of Health-System Pharmacists, Inc. represents that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. makes no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. does not endorse or recommend the use of any drug. The information is not a substitute for medical care.

AHFS^® Patient Medication Information™. © Copyright, 2024. The American Society of Health-System Pharmacists^®, 4500 East-West Highway, Suite 900, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by ASHP.

Selected Revisions: October 15, 2022.

This information does not replace the advice of a doctor. Ignite Healthwise, LLC, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Ignite Healthwise, LLC.

<cipublic-spinner variant="large"><span>Loading…</span></cipublic-spinner>

Page Footer

I want to...

Get an ID card

File a claim

View my claims and EOBs

Check coverage under my plan

See prescription drug list

Find an in-network doctor, dentist, or facility

Find a form

Find 1095-B tax form information

View the Cigna Glossary

Contact Cigna

Audiences

Individuals and Families

Medicare

Employers

Brokers

Providers

Secure Member Sites

myCigna member portal

Health Care Provider portal

Cigna for Employers

Client Resource Portal

Cigna for Brokers

The Cigna Group Information

About Cigna Healthcare

Company Profile

Careers

Newsroom

Investors

Suppliers

The Cigna Group

Third Party Administrators

International

Evernorth

Privacy

Legal

Product Disclosures

Cigna Company Names

Customer Rights

Accessibility

Non-Discrimination Notice

Language Assistance [PDF]

Report Fraud

Sitemap

Cookie Settings

Disclaimer

Individual and family medical and dental insurance plans are insured by Cigna Health and Life Insurance Company (CHLIC), Cigna HealthCare of Arizona, Inc., Cigna HealthCare of Illinois, Inc., Cigna HealthCare of Georgia, Inc., Cigna HealthCare of North Carolina, Inc., Cigna HealthCare of South Carolina, Inc., and Cigna HealthCare of Texas, Inc. Group health insurance and health benefit plans are insured or administered by CHLIC, Connecticut General Life Insurance Company (CGLIC), or their affiliates (see a listing of the legal entities that insure or administer group HMO, dental HMO, and other products or services in your state). Accidental Injury, Critical Illness, and Hospital Care plans or insurance policies are distributed exclusively by or through operating subsidiaries of Cigna Corporation, are administered by Cigna Health and Life Insurance Company, and are insured by either (i) Cigna Health and Life Insurance Company (Bloomfield, CT); (ii) Life Insurance Company of North America (“LINA”) (Philadelphia, PA); or (iii) New York Life Group Insurance Company of NY (“NYLGICNY”) (New York, NY), formerly known as Cigna Life Insurance Company of New York. The Cigna name, logo, and other Cigna marks are owned by Cigna Intellectual Property, Inc. LINA and NYLGICNY are not affiliates of Cigna.

All insurance policies and group benefit plans contain exclusions and limitations. For availability, costs and complete details of coverage, contact a licensed agent or Cigna sales representative. This website is not intended for residents of New Mexico.

Selecting these links will take you away from Cigna.com to another website, which may be a non-Cigna website. Cigna may not control the content or links of non-Cigna websites. Details